Biology of Blood and Marrow Transplantation
Volume 17, Issue 1 , Pages 48-60 , January 2011

Combined Effects of Interleukin-7 and Stem Cell Factor Administration on Lymphopoiesis after Murine Bone Marrow Transplantation

  • Brile Chung

      Affiliations

    • Division of Stem Cell Transplantation, Department of Pediatrics and Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, California
    • ,
  • Dullei Min

      Affiliations

    • Division of Stem Cell Transplantation, Department of Pediatrics and Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, California
    • ,
  • Lukas W. Joo

      Affiliations

    • Division of Research Immunology and Bone Marrow Transplantation, Children’s Hospital Los Angeles, Los Angeles, California
    • ,
  • Mark R. Krampf

      Affiliations

    • Division of Stem Cell Transplantation, Department of Pediatrics and Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, California
    • ,
  • Jing Huang

      Affiliations

    • Division of Stem Cell Transplantation, Department of Pediatrics and Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, California
    • ,
  • Yujun Yang

      Affiliations

    • Division of Stem Cell Transplantation, Department of Pediatrics and Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, California
    • ,
  • Sumana Shashidhar

      Affiliations

    • Division of Stem Cell Transplantation, Department of Pediatrics and Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, California
    • ,
  • Janice Brown

      Affiliations

    • Division of Stem Cell Transplantation, Department of Pediatrics and Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, California
    • ,
  • Eric P. Dudl

      Affiliations

    • Division of Research Immunology and Bone Marrow Transplantation, Children’s Hospital Los Angeles, Los Angeles, California
    • ,
  • Kenneth I. Weinberg

      Affiliations

    • Division of Stem Cell Transplantation, Department of Pediatrics and Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, California
    • Corresponding Author InformationCorrespondence and reprint requests: Kenneth I. Weinberg, MD, Department of Pediatrics, Stanford University School of Medicine, 1000 Welch Road, Suite 301, Palo Alto, CA 94304.

Received 7 April 2010 ,Accepted 29 July 2010.

References 

  1. Socié G, Stone JV, Wingard JR, et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. N Engl J Med. 1999;341:14–21
  2. Ochs L, Shu XO, Miller J, et al. Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients. Blood. 1995;86:3979–3986
  3. Parkman R, Weinberg K. Immunological reconstitution following hematopoietic stem cell transplantation. In:  Thomas ED,  Blume KG,  Forman SJ editor. Hematopoietic Stem Cell Transplantation. 2nd ed. Oxford, UK: Blackwell; 1999;p. 704–711
  4. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature. 1998;396:690–695
  5. Chung B, Barbara-Burnham L, Barsky L, et al. Radiosensitivity of thymic interleukin-7 production and thymopoiesis after bone marrow transplantation. Blood. 2001;98:1601–1606
  6. Mackall CL, Fleisher TA, Brown MR, et al. Age, thymopoiesis, and CD4+ T-cell regeneration after intensive chemotherapy. N Engl J Med. 1995;332:143–149
  7. Hakim FT, Memon SA, Cepeda R, et al. Age-dependent incidence, time course, and consequences of thymic renewal in adults. J Clin Invest. 2005;115:930–939
  8. Min D, Taylor PA, Panoskaltsis-Mortari A, et al. Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood. 2002;99:4592–4600
  9. Chung B, Dudl EP, Min D, et al. Prevention of graft-versus-host disease by anti–IL-7R alpha antibody. Blood. 2007;110:2803–2810
  10. Shinha ML, Fry TJ, Fowler DH, et al. Interleukin 7 worsens graft-versus-host disease. Blood. 2002;100:2642–2649
  11. Alpdogan O, Hubbard VM, Smith OM, et al. Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration. Blood. 2006;107:2453–2460
  12. Weinberg K, Blazar BR, Wagner JE, et al. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood. 2001;97:1458–1466
  13. Small TN, Papadopoulos EB, Boulad F, et al. Comparison of immune reconstitution after unrelated and related T-cell–depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood. 1999;93:467–480
  14. Rossi S, Blazar BR, Farrell CL, et al. Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease. Blood. 2002;100:682–691
  15. Aversa F, Tabilio A, Velardi A, et al. Treatment of high-risk acute leukemia with T-cell–depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med. 1998;339:1186–1193
  16. Broudy VC. Stem cell factor and hematopoiesis. Blood. 1997;90:1345–1364
  17. Murray R, Suda T, Wrighton N, et al. IL-7 is a growth and maintenance factor for mature and immature thymocyte subsets. Int Immunol. 1989;169:707–716
  18. Pechon JJ, Morrissey PJ, Grabstein KH, et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor–deficient mice. J Exp Med. 1994;180:1955–1960
  19. Somberg R, Robinson JP, Felsburg P. T lymphocyte development and function in dogs with X-linked severe combined immune deficiency. J Immunol. 1994;153:4006
  20. Noguchi M, Yi H, Rosenblatt HM, et al. Interleukin 2 receptor γ chain mutation results in X-linked severe combined immune deficiency in humans. Cell. 1993;73:147
  21. Puel A, Ziegler SF, Buckley RH, et al. Defective IL7R expression in T(−)B(+)NK(+) severe combined immunodeficiency. Nat Genet. 1998;20:394–397
  22. Bolotin E, Smogorzewska M, Smith S, et al. Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood. 1996;88:1887–1894
  23. Mackall CL, Fry TJ, Bare C, et al. IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood. 2001;97:1491–1497
  24. Sportes C, Hakim FT, Memon SA, et al. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naïve T cell subsets. J Exp Med. 2008;205:1701–1714
  25. Rosenberg SA, Sportes C, Ahmadzadeh M, et al. IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells. J Immunother. 2006;29:313–319
  26. Rodewald HR, Kretzschmar K, Swat W, et al. Intrathymically expressed c-kit ligand (stem cell factor) is a major factor driving expansion of very immature thymocytes in vivo. Immunity. 1995;3:313–319
  27. Godfrey DI, Zlotnik A, Suda T. Phenotypic and functional characterization of c-kit expression during intrathymic T cell development. J Immunol. 1992;149:2281–2285
  28. Massa S, Balciunaite G, Ceredig R, et al. Critical role for c-kit (CD117) in T cell lineage commitment and early thymocyte development in vitro. Eur J Immunol. 2006;36:526–532
  29. Wu H, Klingmuller U, Besmer P, et al. Interaction of the erythropoietin and stem-cell factor receptors. Nature. 1995;377:242–246
  30. Liu L, Cutler RL, Mui AL, et al. Steel factor stimulates the serine/threonine phosphorylation of the interleukin-3 receptor. J Biol Chem. 1994;269:1677–1679
  31. Rodewald H-R, Ogawa M, Haller C, et al. Pro-thymocyte expansion by c-kit and the common cytokine receptor γ chain is essential for repertoire formation. Immunity. 1997;6:265–272
  32. Jahn T, Sindhu S, Gooch S, et al. Direct interaction between Kit and the interleukin-7 receptor. Blood. 2007;110:1840–1847
  33. Toyama A, Chung B, Brown J, et al. Essential roles for IL-7 and c-kit signaling pathways in fetal and post-natal thymopoiesis. Manuscript in preparation.
  34. Sportoletti P, Del Papa B, De Ioanni M, et al. Interleukin-7–engineered mesenchymal cells: in vitro effects on naïve T-cell population. Biol Blood Marrow Transplant. 2006;12:1250–1260
  35. Di Ianni M, Papa BD, De Ioanni M, et al. Interleukin 7–engineered stromal cells: a new approach for hastening naïve T cell recruitment. Hum Gene Ther. 2005;16:752–764
  36. Devine SM, Hoffman R. Role of mesenchymal stem cells in hematopoietic stem cell transplantation. Curr Opin Hematol. 2000;7:358–363
  37. Nolta JA, Hanley MB, Kohn DB. Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: analysis of gene transduction of long-lived progenitors. Blood. 1994;83:3041–3051
  38. Ren YX, Finckenstein FG, Abdueva DA, et al. Mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations. Cancer Res. 2008;68:6587–6597
  39. Morrissey PJ, McKenna H, Widmer MB, et al. Steel factor (c-kit ligand) stimulates the in vitro growth of immature CD3−/CD4−/CD8− thymocytes: synergy with IL-7. Cells Immunol. 1994;157:118–131
  40. Kees UR, Ford J. Synergistic action of stem cell factor and interleukin-7 in a human immature T-cell line. Immunology. 1999;96:202–206
  41. Schimitt C, Ktorza S, Sarun S, et al. CD34-expressing human thymocyte precursors proliferate in response to interleukin-7 but have lost myeloid differentiation potential. Blood. 1993;82:3675–3685
  42. Sanchez M, Alfani E, Migiaccio AR, et al. Amplification of T cells from human cord blood in serum-deprived culture stimulated with stem cell factor, interleukin-7, and interleukin-2. Bone Marrow Transplant. 2003;31:713–723
  43. Akashi K, Weissman IL. The c-kit+ maturation pathway in mouse thymic T cell development: lineages and selection. Immunity. 1996;147–161
  44. Martin CH, Aifantis I, Scimone ML, et al. Efficient thymic immigration of B220+ lymphoid-restricted bone marrow cells with T precursor potential. Nat Immunol. 2003;4:866–873
  45. Bhandoola A, von Boehmer H, Petrie HT, et al. Commitment and development potential of extrathymic and intrathymic T cell precursors: plenty to choose from. Immunity. 2007;26:678–689
  46. Krueger A, Garbe Al, von Boehmer H. Phenotypic plasticity of T cell progenitors upon exposure to Notch ligands. J Exp Med. 2006;203:1977–1984
  47. Arber C, BitMansour A, Sparer TE, et al. Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation. Blood. 2003;102:421–428
  48. Bodine DM, Seidel NE, Zsebo KM, et al. In vivo administration of stem cell factor to mice increases the absolute number of pluripotent hematopoietic stem cells. Blood. 1993;82:445–455
  49. Dudl E, Chung B, Arber C, et al. Effects of common gamma and kit signals on lymphohematopoietic populations in vivo. Manuscript in preparation.
  50. Fahlman C, Blomhoff HK, Veiby OP, et al. Stem cell factor and interleukin-7 synergize to enhance early myelopoiesis in vitro. Blood. 1994;84:1450–1456
  51. Zlotoff DA, Schwarz BA, Bhandoola A. The long road to the thymus: the generation, mobilization, and circulation of T-cell progenitors in mouse and man. Semin Immunopathol. 2008;30:371–382
  52. Noort WA, Kruisselbrink AB, int’t Anker PS, et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol. 2002;30:870–878
  53. Battiwalla M, Hematti P. Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy. 2009;11:503–515
  54. Le Blanc K, Samuelsson H, Gustafsson B, et al. Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia. 2007;21:1733–1738
  55. Le Blanc K, Ringden O. Mesenchymal stem cells: properties and role in clinical bone marrow transplantation. Curr Opin Immunol. 2006;18:586–591
  56. Chung B, Dudl E, Toyama A, et al. IL-7 is necessary for the development of experimental graft-versus-host disease. Biol Blood Marrow Transplant. 2008;14:16–27

 Financial disclosure: See Acknowledgments on page 59.

PII: S1083-8791(10)00342-3

doi: 10.1016/j.bbmt.2010.07.027

Biology of Blood and Marrow Transplantation
Volume 17, Issue 1 , Pages 48-60 , January 2011

Article Tools

* Image Usage & Resolution